Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004336:Drug Antagonism; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D010276:Parasympatholytics / Q000494:pharmacology*; D010654:Phenylbutyrates / Q000494:pharmacology*; D011413:Propantheline / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D051381:Rats; D012472:Salivation / Q000187:drug effects; D012601:Scopolamine / Q000494:pharmacology; D013276:Stomach Ulcer / Q000517:prevention & control; D014202:Tremor / Q000517:prevention & control; D014203:Tremorine / Q000037:antagonists & inhibitors
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010654:Phenylbutyrates; D000644:Quaternary Ammonium Compounds; D011413:Propantheline; D001285:Atropine; D012601:Scopolamine; D000109:Acetylcholine; D014203:Tremorine